Thu 26 Nov 2009 | 8:18 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation (NYMX.O) (Consolidated Issue listed on NASDAQ Capital Market)

sector: Healthcare . industry: Biotechnology · View NYMX on other exchanges

As of 25 Nov 2009

4.54USD

Price Change

-0.03

Percent Change

-0.60%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Doyle, Brian	54	2003	Senior Manager - Global Sales and Marketing
McDonald, Paul	83	2006	Director
Lanham, Randall	45	2006	Director
Guy, Roger	58	2006	Director
Morse, David	52	2006	Director
Gemmell, Jack	57	--	Chief Information Officer, General Counsel, Director
Wolvin, Roy	54	1995	Chief Financial Officer, Treasurer, Secretary
Dupuis, Celine	50	2004	Chief Clinical Officer
Averback, Paul	58	2006	Chairman of the Board, President, Chief Executive Officer

Find out more about NYMX.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.